imiquimod has been researched along with Local Neoplasm Recurrence in 121 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 31 (25.62) | 29.6817 |
2010's | 63 (52.07) | 24.3611 |
2020's | 27 (22.31) | 2.80 |
Authors | Studies |
---|---|
Jiang, J; Kuai, L; Li, B; Li, X; Liu, T; Luo, Y; Ru, Y; Song, J; Sun, X; Xing, M; Zhang, H | 1 |
Jonnalagadda, S; Palle, K; Reedy, M | 1 |
Álvarez-Chinchilla, P; Bañuls-Roca, J; Hispán-Ocete, P; Poveda-Montoyo, I; Schneller-Pavelescu, L | 2 |
Hou, JJ; Jia, HY; Qiu, HY; Wu, Y; Zhang, MD; Zhou, ML | 1 |
Liu, X; Wang, C; Yang, Z; Zhang, D; Zhang, J; Zhao, M; Zhou, C; Zhu, S | 1 |
Bedane, C; Bens, G; Beylot-Barry, M; Bossard, C; Daude, M; Debarbieux, S; Denis, MG; Dinulescu, M; Dréno, B; Khammari, A; Le Duff, F; Leccia, MT; Legoupil, D; Machet, L; Maillard, H; Meyer, N; Monestier, S; Nguyen, JM; Vergier, B; Wierzbicka-Hainaut, E | 1 |
Javed, MU; Kaur, A; Murison, M; Venables, B; Yarrow, J | 1 |
Cao, X; Xue, R; Yuan, X | 1 |
Gou, M; Huang, M; Huang, Y; Kang, T; Li, Y; Liu, J; Wang, S; Wang, Y; Wei, X; Xiong, M; Yang, L; Zhu, J | 1 |
Kulakov, EL; Logan, IT; Perrett, CM | 1 |
Arits, AHMM; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Sinx, KAE; Winnepenninckx, VJL | 1 |
Carnevale, C; D'Argenio, P; Diociaiuti, A; El Hachem, M; Giancristoforo, S; Lucchetti, MC; Rotunno, R; Tchidjou, HK | 1 |
Haidopoulos, D; Pergialiotis, V; Rodolakis, A; Rountis, A; Tsetsa, P | 1 |
Bartenjev, I; Bartenjev, MS; Isaković-Vidović, S | 1 |
Carton, I; Henno, S; Lavoué, V; Lebreton, M; Levêque, J; Nyangoh-Timoh, K; Tesson, C | 1 |
Brogden, DRL; Kontovounisios, C; Mills, SC; Pellino, G; Tekkis, P; Walsh, U | 1 |
Bath-Hextall, FJ; Hogan, S; Leonardi-Bee, J; Thomson, J; Williams, HC | 2 |
Choi, S; Chung, KY; Oh, BH; Oh, Y; Roh, MR | 1 |
Badiavas, EV; Gonzalez, AM; Kirsner, RS; Moore, K; Nagrani, N; Nahm, WJ; Nichols, AJ; Shen, J; Zito, PM | 1 |
Baker, C; Chambers, M; Chapman, MS; Saunders, E; Swetter, SM | 1 |
Piqué-Duran, E | 1 |
Catorze, G; Labareda, J; Miroux Catarino, A; Queirós, C; Silva, L; Viana, I | 1 |
Giacomantonio, CA; Helyer, LK; Pasternak, S; Peltekian, K; Simms, GA; Stein, J; Vidovic, D; Walsh, M | 1 |
Bennardo, L; Cisale, GY; Nisticò, SP; Pentangelo, G; Provenzano, E | 1 |
Bennardo, F; Bennardo, L; Dastoli, S; Giudice, A; Morrone, P; Nisticò, SP; Passante, M; Patruno, C; Provenzano, E | 1 |
Ahmed, E; El-Khalawany, M; Mosbeh, A; Rageh, MA; Sameh, A; Saudi, WM | 1 |
Chapman, MS; Park, AJ; Paul, J; Samie, FH | 1 |
Baldelli, F; Cavazzoni, E; Leo, CA; Santorelli, C | 1 |
Hutson, R; Nama, V; Parashurama, R | 1 |
Dressler, C; Nast, A; Werner, RN; Westfechtel, L | 1 |
Bostanci, S; Botsali, A; Heper, AO; Kocyigit, P; Vural, S | 1 |
Carucci, M; Fiander, A; Hurt, CN; Jones, S; Madden, TA; Naik, R; Nordin, AJ; Powell, N; Tristram, A | 1 |
Shaw, FM; Weinstock, MA | 1 |
Helm, CW | 1 |
Bowen, GM; Bowling, M; Donigan, JM; Goldgar, DE; Hadley, ML; Hyde, MA | 1 |
Fosko, SW; Navarrete-Dechent, CP; Nehal, KS | 1 |
Collier, NJ; Exton, LS; Green, AC; Haylett, AK; Ibbotson, SH; Mallipeddi, R; McKenna, KE; Mohd Mustapa, MF; Morton, CA; Moseley, H; Rhodes, LE; Seukeran, D; Ward, KA; Wong, TH | 1 |
Gerestein, CG; Koeneman, MM; Kruse, AJ; van Beekhuizen, HJ; van de Sande, AJM; van Kemenade, FJ | 1 |
Delman, KA; Farley, CR; Lopez-Aguiar, AG; Lowe, MC; Oh, G; Russell, MC | 1 |
Bulten, J; de Hullu, JA; Fons, G; Lok, CAR; Massuger, LFAG; Oonk, MHM; Slangen, BMF; van der Linden, M; van Doorn, HC; van Dorst, EBL; van Poelgeest, MIE | 1 |
Brand, FL; Hunger, RE; Seyed Jafari, SM | 1 |
Innamaa, A; Lippiatt, J; Melson, L; Mujukian, A | 1 |
Bouceiro-Mendes, R; Correia-Fonseca, I; Mendonça-Sanches, M; Soares-de-Almeida, L | 1 |
Bassett, RL; Chon, S; Fox, PS; McKay, KM; Prieto, VG; Sambrano, BL | 1 |
Assorgi, C; Biamonti, A; Catalano, A; Cozza, G; Frega, A; Gentile, M; Lombardi, D; Maniglio, P; Marziani, R; Milazzo, GN; Moscarini, M; Ricciardi, E; Scirpa, P; Sesti, F; Sopracordevole, F | 1 |
Bassukas, ID; Gaitanis, G | 1 |
Nelson, EL; Stockdale, CK | 1 |
Bath-Hextall, FJ; Leonardi-Bee, J; Matin, RN; Wilkinson, D | 1 |
Bassukas, ID; Nakuçi, M | 1 |
Chen, FP | 1 |
Buttmann, N; Clad, A; Gieseking, F; Harter, P; Lellé, RJ; Luyten, A; Maass-Poppenhusen, K; Petry, KU; Sörgel, P | 1 |
Jiayuan, C; Jing, W; Juan, X; Li, X; Qin, H; Qing, L; Shengmei, X | 1 |
Bassukas, ID; Gaitanis, G; Kempf, W; Markatseli, TE; Voulgari, PV | 1 |
Biamonti, A; Bianchi, P; Caserta, D; Catalano, A; Cozza, G; Di Martino, G; Frega, A; Gentile, M; Marziani, R; Milazzo, GN; Schimberni, M; Scirpa, P; Sesti, F; Sopracordevole, F; Zinna, M | 1 |
Gao, X; Geng, L; Shi, J; Wang, H; Xu, Y | 1 |
den Hollander, JC; van der Ende, ME; van der Snoek, EM | 1 |
Carneiro, RC; de Lima, PP; de Macedo, EM; Matayoshi, S; Silva, BG | 1 |
Cohen, JL; Friedman, A; Ruiz, ES | 1 |
Karia, PS; Mora, AN; Nguyen, BM | 1 |
Barlow, R; Coleman, A; Craythorne, EE; Kai, AC; Mallipeddi, R; Richards, T | 1 |
Baumgartner, M; Gadaldi, K; Gautschi, M; Hunger, RE; Oberholzer, PA; Yawalkar, N | 1 |
de Vries, K; Greveling, K; Prens, EP; van Doorn, MB | 1 |
Bryant, A; Chakrabarti, M; Kaushik, S; Lawrie, TA; Nordin, A; Pepas, L | 1 |
Abu-Rustum, NR; Backes, FJ; Black, DR; Chi, DS; Cowan, RA; Eisenhauer, EL; Gardner, GJ; Hoang, LN; Leitao, MM; Park, KJ; Soslow, RA | 1 |
Arits, AHMM; de Rooij, MJM; Essers, BAB; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Roozeboom, MH; Sommer, A; Steijlen, PM | 1 |
Armstrong, SJ; Bath-Hextall, F; Colver, GB; Miller, PSJ; Ozolins, M; Perkins, W; Williams, HC | 1 |
Hoekzema, R; Jansma, EP; Prinsen, CAC; Tio, D; van der Woude, J; van Montfrans, C | 1 |
Gioia Di Chiacchio, N; Haneke, E; le Voci, F; Ocampo-Garza, J; Paschoal, FM | 1 |
Affleck, AG; Evans, A; Ezughah, FI; Fleming, CJ; Ibbotson, SH | 1 |
Geisler, JP; Manahan, KJ | 1 |
Carroll, S; Czarnecki, C; Czarnecki, D | 1 |
Balkrishnan, R; Feldman, SR; Karve, SJ; Pearce, DJ; Yentzer, BA | 1 |
Baer, KE; Bergman, PJ; Craft, D; Gill, VL; Leung, C | 1 |
McCall, MW; Woodmansee, CS | 1 |
Brightman, L; Daniel, DR; Geronemus, RG; Mahlberg, MJ; Mintzis, MM; Sukal, SA | 1 |
Cordoro, KM; Greer, KE; Lonergan, CL; McNamara, EK | 1 |
Bertozzi, S; Fruscalzo, A; Lellé, RJ; Londero, AP; Marchesoni, D | 1 |
De'Ambrosis, B; Gebauer, K; Meng, TC; Quirk, C; Slade, HB | 1 |
Ayers, D; Kenealy, J; O'Neill, J | 1 |
Güngor, T; Ozat, M; Sahin, I; Sirvan, L; Tonguc, E; Var, T | 1 |
Bordeaux, JS; Capaldi, L; Maloney, ME; Martires, KJ; Pattee, SF | 1 |
Bruckner-Tuderman, L; Burger, B; Has, C; Itin, P; Kohlhase, J; Volz, A | 1 |
Aguayo-Leiva, IR; Jaén-Olasolo, P; Ríos-Buceta, L | 1 |
Borden, E; Triozzi, PL; Tuthill, RJ | 1 |
Gil-Bistes, D; Guillot, B; Kluger, N; Rigau, V | 1 |
Caminal, JM; Fabra, A; Ferreres, JR; Marcoval, J; Penín, RM; Piulats, JM | 1 |
Badiglian-Filho, L; Baiocchi, G; Begnami, MD; Costa, FD; Faloppa, CC; Fukazawa, EM; Kumagai, LY; Oliveira, RA; Soares, FA; Surima, WS | 1 |
Bogatch, K; Carvajal, RD; Chapman, PB; Chi, DS; Costantino, PD; Flavin, M; Gardner, GJ; Pulitzer, MP; Schwartz, GK; Smyth, EC; Wolchok, JD | 1 |
Chu, J; Hartman, R; Meehan, S; Patel, R; Stein, JA | 1 |
Guillén, C; Llombart, B; Messeguer, F; Requena, C; Serra-Guillén, C | 1 |
Borrego, J; Figueiredo, A; Paula, T; Ribeiro, F | 1 |
Guillén, C; Hilari, H; Llombart, B; Llorca, D; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillén, C; Traves, V; Villanueva, A | 1 |
Brown, J; Frumovitz, M; Milbourne, AM; Munsell, MF; Rhodes, HE; Schmeler, KM; Trimble, CL; Wallbillich, JJ | 1 |
Brodell, RT; Tandon, Y | 1 |
Adams, S; Babb, JS; Demaria, S; Dewan, MZ; DiNapoli, S; Formenti, SC; Kawashima, N; Vanpouille-Box, C | 1 |
Clad, A; Fischer, A; Westermann, C | 1 |
Binder, B; Cerroni, L; Kerl, H; Richtig, E; Smolle, J; Wolf, IH | 1 |
Awada, A; Heenen, M; Laporte, M; Mathieu, A; Petein, M; Velu, T; Vereecken, P | 1 |
Epstein, E | 1 |
Fisher, GH; Lang, PG | 1 |
Blanchard, A; Busbey, S; Judge, DE; Lorincz, AA; Medenica, MM; Wang, LC | 1 |
Beyeler, M; Burg, G; Dummer, R; Morcinek, J | 1 |
Aebi, S; Caversaccio, M | 1 |
Kerl, H; Kopera, D; Richtig, E; Wolf, IH | 1 |
Bauer, J; Eigentler, TK; Garbe, C; Kamin, A; Radny, P; Weide, B | 1 |
Markus, J; Orengo, I; Pielop, JA; Rivera, A | 1 |
Ceilley, RI; Del Rosso, JQ | 1 |
Diaz, SF; Gilbert, S; Jessen, C; Malone, ED; Nogueira, SA; Torres, SM | 1 |
Gebauer, K; Owens, M; Quirk, C; Stampone, P | 1 |
Li, LJ; Wagamon, K | 1 |
Bodman-Smith, MD; Dalgleish, AG; Fischer, MD; Green, DS | 1 |
Kirtschig, G; van Doorn, R; van Meurs, T | 1 |
Carroll, MT; Tillman, DK | 2 |
Offner, F; Schiessl, C; Strohal, R; Tauber, M; Wolber, C | 1 |
Fenske, NA; Glass, LF; Prakash, AV; Shistik, G | 1 |
Ely, H; Rigel, DS; Torres, AM | 1 |
Davis, G; Richard, J; Wentworth, J | 1 |
Jayne, CJ; Kaufman, RH | 1 |
23 review(s) available for imiquimod and Local Neoplasm Recurrence
Article | Year |
---|---|
Network meta-analysis of treatments for perineal extramammary paget's disease: Focusing on performance of recurrence prevention.
Topics: Bayes Theorem; Female; Humans; Imiquimod; Male; Mohs Surgery; Neoplasm Recurrence, Local; Network Meta-Analysis; Paget Disease, Extramammary; Retrospective Studies | 2023 |
Management options for vaginal intraepithelial neoplasia.
Topics: Carcinoma in Situ; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Retrospective Studies; Vaginal Neoplasms | 2020 |
Paget's disease of the vulva: A challenge for the gynaecologist.
Topics: Administration, Topical; Antineoplastic Agents; Diagnosis, Differential; Female; Humans; Imiquimod; Lasers, Gas; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Photochemotherapy; Prognosis; Radiotherapy Dosage; Vulvar Neoplasms | 2021 |
Evaluating the efficacy of treatment options for anal intraepithelial neoplasia: a systematic review.
Topics: Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; HIV Infections; Humans; Imiquimod; Neoplasm Recurrence, Local; Papillomavirus Infections | 2021 |
Interventions for basal cell carcinoma of the skin.
Topics: Adult; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Basal Cell; Cryotherapy; Female; Humans; Imiquimod; Immunocompetence; Laser Therapy; Male; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Radiotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome | 2020 |
Interventions for basal cell carcinoma: abridged Cochrane systematic review and GRADE assessments.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Humans; Imiquimod; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Skin Neoplasms; Young Adult | 2021 |
Case Report: Combined Intra-Lesional IL-2 and Topical Imiquimod Safely and Effectively Clears Multi-Focal, High Grade Cutaneous Squamous Cell Cancer in a Combined Liver and Kidney Transplant Patient.
Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Graft Rejection; Humans; Imiquimod; Immunocompromised Host; Immunosuppression Therapy; Infusions, Intralesional; Interleukin-2; Kidney Transplantation; Liver Transplantation; Male; Neoplasm Recurrence, Local; Skin Neoplasms; Transplant Recipients; Treatment Outcome | 2021 |
Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far?
Topics: Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms | 2021 |
Anogenital warts and other HPV-associated anogenital lesions in the HIV-positive patient: a systematic review and meta-analysis of the efficacy and safety of interventions assessed in controlled clinical trials.
Topics: Aminoquinolines; Antiviral Agents; Anus Diseases; Coinfection; Female; Genital Diseases, Female; Genital Diseases, Male; HIV Seropositivity; Humans; Imiquimod; Immunocompetence; Male; Neoplasm Recurrence, Local; Papillomavirus Infections; Randomized Controlled Trials as Topic; Warts | 2017 |
Conventional and combination topical photodynamic therapy for basal cell carcinoma: systematic review and meta-analysis.
Topics: Administration, Topical; Antineoplastic Agents; Carcinoma, Basal Cell; Cryosurgery; Dose Fractionation, Radiation; Esthetics; Humans; Imiquimod; Neoplasm Recurrence, Local; Pain; Pain Measurement; Patient Safety; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome | 2018 |
Interventions for cutaneous Bowen's disease.
Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Cryotherapy; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2013 |
Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis.
Topics: Administration, Topical; Aminoquinolines; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Incidence; Neoplasm Recurrence, Local; Photochemotherapy; Skin Neoplasms; Time Factors | 2015 |
Before or after: is there a connection between the use of adjunctive nonmelanoma skin cancer treatments and subsequent invasive tumors?
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Skin Neoplasms | 2015 |
A quantitative systematic review of the efficacy of imiquimod monotherapy for lentigo maligna and an analysis of factors that affect tumor clearance.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Assessment; Skin Neoplasms; Survival Rate; Treatment Outcome | 2015 |
Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Cytosine; Disease Progression; Female; Humans; Imiquimod; Indoles; Laser Therapy; Neoplasm Recurrence, Local; Organophosphonates; Photochemotherapy; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome; Vulvar Neoplasms | 2016 |
A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.
Topics: Aminoquinolines; Antineoplastic Agents; Disease Progression; Drug Administration Schedule; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Skin Neoplasms | 2017 |
Imiquimod: a review of basal cell carcinoma treatments.
Topics: Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Mohs Surgery; Neoplasm Recurrence, Local; Neoplasms, Basal Cell; Quality of Life; Skin Neoplasms | 2008 |
[Paget disease of the vulva: resolution after local treatment with imiquimod--report of a case and review of the literature].
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Chemotherapy, Adjuvant; Colposcopy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Imiquimod; Laser Therapy; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Vulva; Vulvar Neoplasms | 2009 |
Treatment of recurrent vulvar Paget disease with imiquimod cream: a case report and review of the literature.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Betamethasone; Emollients; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Treatment Outcome; Vulvar Neoplasms | 2011 |
Extramammary Paget disease.
Topics: Aminoquinolines; Antineoplastic Agents; Asian People; Biopsy; Carcinoma, Squamous Cell; Combined Modality Therapy; Diagnostic Errors; Eczema; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Penile Neoplasms; Scrotum; Skin Neoplasms | 2011 |
Local reactions to imiquimod in the treatment of basal cell carcinoma.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Keratosis, Actinic; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome | 2012 |
[Cutaneous neoplasms].
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Hemangiosarcoma; HIV Infections; Humans; Imiquimod; Immunotherapy; Keratosis; Lymph Node Excision; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Neoplasm Recurrence, Local; Photochemotherapy; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin; Skin Neoplasms; Time Factors | 2003 |
Current modalities and new advances in the treatment of basal cell carcinoma.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cryosurgery; Curettage; Electrosurgery; Humans; Imiquimod; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Skin Neoplasms | 2006 |
18 trial(s) available for imiquimod and Local Neoplasm Recurrence
Article | Year |
---|---|
Efficacy of imiquimod in the management of lentigo maligna.
Topics: Aminoquinolines; Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms | 2023 |
Surgery versus combined treatment with curettage and imiquimod for nodular basal cell carcinoma: One-year results of a noninferiority, randomized, controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Basal Cell; Combined Modality Therapy; Curettage; Dermatologic Surgical Procedures; Disease-Free Survival; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Skin; Skin Cream; Skin Neoplasms | 2020 |
Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN).
Topics: Administration, Topical; Antineoplastic Agents; Carcinoma in Situ; Cidofovir; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Treatment Outcome; Vulvar Neoplasms | 2018 |
TOPical Imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia (TOPIC-2 trial): a study protocol for a randomized controlled trial.
Topics: Adult; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Research Design; Single-Blind Method; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2018 |
Immunocryosurgery for non-superficial basal cell carcinoma: a pro-spective, open-label phase III study for tumours ≤ 2 cm in diameter.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Facial Neoplasms; Feasibility Studies; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms; Treatment Failure; Tumor Burden | 2014 |
Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Female; Follow-Up Studies; Humans; Imiquimod; Male; Neoplasm Recurrence, Local; Prospective Studies; Skin Cream; Treatment Outcome | 2015 |
Prognostic markers in lentigo maligna patients treated with imiquimod cream: A long-term follow-up study.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biomarkers, Tumor; Biopsy, Needle; Disease-Free Survival; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunohistochemistry; Male; Melanocytes; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Risk Assessment; Skin Cream; Skin Neoplasms; Switzerland; Time Factors; Treatment Outcome | 2016 |
A pilot study of topical imiquimod therapy for the treatment of recurrent extramammary Paget's disease.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Pilot Projects | 2016 |
Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial.
Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Proportional Hazards Models; Single-Blind Method; Skin Neoplasms; Treatment Outcome | 2016 |
Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Child; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Young Adult | 2017 |
Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Follow-Up Studies; Histocytological Preparation Techniques; Humans; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Skin; Skin Neoplasms; Treatment Outcome | 2008 |
Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms; Treatment Outcome | 2010 |
Efficacy of imiquimod 5% cream in the treatment of equine sarcoids: a pilot study.
Topics: Administration, Cutaneous; Aminoquinolines; Animals; Antineoplastic Agents; Female; Horse Diseases; Horses; Imiquimod; Male; Neoplasm Recurrence, Local; Pilot Projects; Skin Neoplasms; Treatment Outcome | 2006 |
Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Australia; Carcinoma, Basal Cell; Drug Administration Schedule; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; New Zealand; Severity of Illness Index; Skin Neoplasms; Treatment Outcome | 2006 |
Phase I/II study of topical imiquimod and intralesional interleukin-2 in the treatment of accessible metastases in malignant melanoma.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Female; Humans; Imiquimod; Injections, Intralesional; Interleukin-2; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Ointments; Skin Neoplasms; Treatment Outcome | 2007 |
Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome | 2007 |
Imiquimod 5% cream following curettage without electrodesiccation for basal cell carcinoma: preliminary report.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Curettage; Desiccation; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome | 2008 |
A 36-month clinical experience of the effectiveness of curettage and imiquimod 5% cream in the treatment of basal cell carcinoma.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Combined Modality Therapy; Curettage; Electrosurgery; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Skin Neoplasms | 2008 |
80 other study(ies) available for imiquimod and Local Neoplasm Recurrence
Article | Year |
---|---|
TMT-based proteomics analysis reveals the protective effect of Jueyin granules on imiquimod-induced psoriasis mouse model by causing autophagy.
Topics: Animals; Autophagy; Disease Models, Animal; Humans; Imiquimod; Mice; Neoplasm Recurrence, Local; Proteomics; Psoriasis | 2022 |
Case Report: Intra-Tumoral Vaccinations of Quadrivalent HPV-L1 Peptide Vaccine With Topical TLR-7 Agonist Following Recurrence: Complete Resolution of HPV-HR-Associated Gynecologic Squamous Cell Carcinomas in Two Patients.
Topics: Adult; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Imiquimod; Neoplasm Recurrence, Local; Papillomavirus Infections; Salvage Therapy; Toll-Like Receptor 7 | 2021 |
Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences.
Topics: Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms | 2022 |
Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences.
Topics: Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms | 2022 |
Lenalidomide attenuates IMQ-induced inflammation in a mouse model of psoriasis.
Topics: Animals; Disease Models, Animal; Imiquimod; Inflammation; Lenalidomide; Mice; Mice, Inbred BALB C; Neoplasm Recurrence, Local; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Psoriasis; Skin; Tumor Microenvironment | 2022 |
Long-lasting postoperative analgesia with local anesthetic-loaded hydrogels prevent tumor recurrence via enhancing CD8
Topics: Analgesia; Anesthetics, Local; CD8-Positive T-Lymphocytes; Humans; Imiquimod; Neoplasm Recurrence, Local; Pain, Postoperative; Quality of Life; Ropivacaine; T-Lymphocytes | 2023 |
Rate of recurrence following treatment of lentigo maligna with carbon dioxide laser alone or in combination with imiquimod: Results of a long-term study.
Topics: Antineoplastic Agents; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Lasers, Gas; Longitudinal Studies; Neoplasm Recurrence, Local; Skin Neoplasms | 2023 |
Modular Engineering of Targeted Dual-Drug Nanoassemblies for Cancer Chemoimmunotherapy.
Topics: Animals; Antigen Presentation; Apoptosis; Cell Line, Tumor; Drug Delivery Systems; Drug Liberation; Drug Therapy; Female; Imiquimod; Immunotherapy; Mice, Inbred BALB C; Nanoparticles; Neoplasm Recurrence, Local; Neoplasms; Paclitaxel; Rats, Sprague-Dawley; Tissue Distribution | 2019 |
Sequential Treatment of Superficial Basal Cell Carcinomas With Topical Methyl Aminolevulinate Photodynamic Therapy and Imiquimod 5% Cream: A Retrospective Study of Clinical and Cosmetic Outcomes.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Combined Modality Therapy; Esthetics; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Cream; Skin Neoplasms; Treatment Outcome | 2020 |
Successful topical treatment of anal giant condylomata acuminata in an infant.
Topics: Administration, Topical; Aminoquinolines; Child; Condylomata Acuminata; Humans; Imiquimod; Infant; Neoplasm Recurrence, Local | 2020 |
Topical Imiquimod for Management of Recurrent Lentigo Maligna Melanoma in Situ.
Topics: Administration, Topical; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms | 2020 |
Initial topical monotherapy may increase the risk of recurrence in patients with extramammary Paget's disease.
Topics: Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Retrospective Studies | 2021 |
A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cost-Benefit Analysis; Cryotherapy; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Tretinoin | 2021 |
Topical Imiquimod for Lentigo Maligna: Survival Analysis of 103 Cases With 17 Years Follow-up.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratolytic Agents; Male; Middle Aged; Neoplasm Recurrence, Local; Nicotinic Acids; Prospective Studies; Retrospective Studies; Skin Neoplasms; Time Factors | 2021 |
Recurrence of a Basal Cell Carcinoma in a Vitiligo-like Area After Imiquimod Treatment.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome; Vitiligo | 2021 |
Topical imiquimod as neoadjuvant therapy before Mohs micrographic surgery for basal cell carcinoma in the head and neck region: findings from a large retrospective study.
Topics: Carcinoma, Basal Cell; Humans; Imiquimod; Mohs Surgery; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2021 |
Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip.
Topics: Aged, 80 and over; Carcinoma, Squamous Cell; Humans; Imiquimod; Lip; Neoplasm Recurrence, Local; Papillomavirus Infections | 2021 |
The combined effect of CO
Topics: Antineoplastic Agents; Carbon Dioxide; Carcinoma, Basal Cell; Diclofenac; Female; Humans; Imiquimod; Lasers, Gas; Male; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome | 2022 |
Long-Term Outcomes of Melanoma In Situ Treated With Topical 5% Imiquimod Cream: A Retrospective Review.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Follow-Up Studies; Humans; Imiquimod; Male; Melanoma; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2017 |
Response to imiquimod 5% cream as treatment for condyloma and anal intraepithelial neoplasia in HIV-positive and HIV-negative patients.
Topics: Administration, Topical; Adult; Aminoquinolines; Anal Canal; Antineoplastic Agents; Anus Neoplasms; Carcinoma in Situ; Condylomata Acuminata; HIV Infections; Humans; Imiquimod; Italy; Male; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome | 2017 |
Paget's Disease of the Vulva: A Review of 20 Years' Experience.
Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Logistic Models; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Vulvar Neoplasms | 2017 |
Long-Term Follow-Up Results of Topical Imiquimod Treatment in Basal Cell Carcinoma.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Cream; Skin Neoplasms; Time Factors | 2018 |
Comparing Topical Treatments for Basal Cell Carcinoma.
Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2018 |
Is cidofovir a better treatment than imiquimod for high-grade vulval intraepithelial neoplasia?
Topics: Carcinoma in Situ; Cidofovir; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Vulvar Neoplasms | 2018 |
Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Nicotinic Acids; Off-Label Use; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2018 |
Lentigo Maligna-Challenges, Observations, Imiquimod, Confocal Microscopy, and Personalized Treatment.
Topics: Aminoquinolines; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Microscopy, Confocal; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Off-Label Use; Skin Neoplasms | 2018 |
Recurrence Patterns after Primary Excision of Invasive Melanoma with Melanoma
Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Male; Margins of Excision; Melanoma; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms | 2018 |
Vulvar Paget disease: A national retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Humans; Imiquimod; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Netherlands; Paget Disease, Extramammary; Retrospective Studies; Survival Rate; Vulvar Neoplasms; Vulvectomy | 2019 |
Confocal Microscopy and Lentigo Maligna: An in vivo Pilot Study for the Assessment of Response to Imiquimod Therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Contraindications, Procedure; Dermatologic Surgical Procedures; Dermoscopy; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Microscopy, Confocal; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Skin Neoplasms; Treatment Outcome | 2019 |
Extensive extramammary Paget's disease of the vulva involving the bladder postradical split skin graft reconstruction.
Topics: Aged, 80 and over; Antineoplastic Agents; Cystoscopy; Female; Gynecologic Surgical Procedures; Humans; Imiquimod; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Skin Transplantation; Urethral Neoplasms; Urinary Bladder Neoplasms; Vulvar Neoplasms | 2019 |
A Case of Chronic and Relapsing Paget Disease of the Vulva.
Topics: Aged; Antineoplastic Agents; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Plastic Surgery Procedures; Treatment Outcome; Vulvar Neoplasms; Vulvectomy | 2019 |
Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness-based definition of sBCC.
Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Failure; Treatment Outcome | 2013 |
Imiquimod 5% cream versus cold knife excision for treatment of VIN 2/3: a five-year follow-up.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Ointments; Vulvar Neoplasms | 2013 |
Vulvar and vaginal HPV disease.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Colposcopy; Condylomata Acuminata; Female; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Interferon Inducers; Middle Aged; Neoplasm Recurrence, Local; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Pregnancy; Pregnancy Complications, Infectious; Sexually Transmitted Diseases; Trichloroacetic Acid; Vaginal Diseases; Vaginal Neoplasms; Vaginal Smears; Vulvar Diseases; Vulvar Neoplasms; Young Adult | 2013 |
Office-based treatment of basal cell carcinoma with immunocryosurgery: feasibility and efficacy.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Ambulatory Care; Aminoquinolines; Carcinoma, Basal Cell; Cohort Studies; Cryosurgery; Feasibility Studies; Female; Follow-Up Studies; Greece; Humans; Imiquimod; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Office Visits; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2013 |
Efficacy of imiquimod 5% cream for persistent human papillomavirus in genital intraepithelial neoplasm.
Topics: Aminoquinolines; Antineoplastic Agents; Cervix Uteri; Chemotherapy, Adjuvant; Female; Follow-Up Studies; Humans; Imiquimod; Neoplasm Recurrence, Local; Papanicolaou Test; Papillomavirus Infections; Retrospective Studies; Severity of Illness Index; Time Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vagina; Vaginal Neoplasms; Vaginal Smears | 2013 |
Treatment of extramammary Paget disease of the vulva with imiquimod: a retrospective, multicenter study by the German Colposcopy Network.
Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Analysis of Variance; Antineoplastic Agents; Cohort Studies; Colposcopy; Female; Follow-Up Studies; Germany; Humans; Imiquimod; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Paget Disease, Extramammary; Retrospective Studies; Risk Assessment; Survival Rate; Treatment Outcome; Vulvar Neoplasms | 2014 |
Complete remission of two patients with recurrent and wide spread extramammary Paget disease obtained from 5-aminolevulinic acid-based photodynamic therapy and imiquimod combination treatment.
Topics: Aged; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Drug Therapy, Combination; Genital Neoplasms, Male; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Photosensitizing Agents; Remission Induction; Skin Neoplasms; Treatment Outcome | 2014 |
In transit recurrence of Merkel cell carcinoma associated with polyarthritis effectively treated with immunocryosurgery.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Arthritis; Carcinoma, Merkel Cell; Cryosurgery; Drug Administration Schedule; Female; Humans; Imiquimod; Immunotherapy; Neoplasm Recurrence, Local; Paraneoplastic Syndromes; Remission Induction; Skin Neoplasms; Treatment Outcome | 2014 |
Adjuvant topical treatment with imiquimod 5% after excisional surgery for VIN 2/3.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Combined Modality Therapy; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Risk Factors; Vulvar Neoplasms | 2014 |
Imiquimod 5% cream for five consecutive days a week in an HIV-infected observational cohort up to 32 weeks in the treatment of high-grade squamous intraepithelial lesions.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Anal Canal; Antineoplastic Agents; Anus Neoplasms; Disease Progression; Electrocoagulation; Female; HIV Seropositivity; Humans; Imiquimod; Male; Neoplasm Recurrence, Local; Ointments; Papillomaviridae; Prospective Studies; Squamous Intraepithelial Lesions of the Cervix | 2015 |
Five-year recurrence rate of lentigo maligna after treatment with imiquimod.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms | 2016 |
A two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod: excellent cosmesis, but frequent recurrences on the nose.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Facial Neoplasms; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Laser Therapy; Leg; Male; Neoplasm Recurrence, Local; Nose Neoplasms; Skin Neoplasms; Treatment Outcome | 2016 |
Subungual Melanoma In Situ Treated With Imiquimod 5% Cream After Conservative Surgery Recurrence.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Humans; Imiquimod; Male; Melanoma; Nails; Neoplasm Recurrence, Local; Skin Cream; Skin Neoplasms; Toes | 2017 |
Imiquimod in vulvar Paget's disease: a case report.
Topics: Aged, 80 and over; Aminoquinolines; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Remission Induction; Treatment Outcome; Vulvar Neoplasms | 2008 |
Imiquimod treatment associated with a reduction in new skin cancer formation.
Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Skin Neoplasms | 2009 |
Use of imiquimod 5% cream (Aldara) in cats with multicentric squamous cell carcinoma in situ: 12 cases (2002-2005).
Topics: Aminoquinolines; Animals; Antineoplastic Agents; Bowen's Disease; Carcinoma in Situ; Carcinoma, Squamous Cell; Cat Diseases; Cats; Female; Imiquimod; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome | 2008 |
Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Skin Neoplasms | 2009 |
What lies beneath? A lesson for the clinician. Intraoperative frozen section appearance of persistent basal cell carcinoma after apparent cure with imiquimod 5% cream.
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Frozen Sections; Humans; Imiquimod; Middle Aged; Mohs Surgery; Neoplasm Recurrence, Local; Ointments | 2009 |
Imiquimod cream 5% for the treatment of arsenic-induced cutaneous neoplasms.
Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Arsenic; Carcinoma, Squamous Cell; Follow-Up Studies; Humans; Imiquimod; Keratosis; Male; Neoplasm Recurrence, Local; Psoriasis; Skin Neoplasms | 2010 |
Periocular lentigo maligna treated with imiquimod.
Topics: Aminoquinolines; Antineoplastic Agents; Eye Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome | 2011 |
Failed treatment of amelanotic lentigo maligna with imiquimod followed by pigment production.
Topics: Administration, Topical; Aminoquinolines; Biopsy, Needle; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunohistochemistry; Melanoma, Amelanotic; Middle Aged; Neoplasm Recurrence, Local; Nose; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2010 |
Mild clinical phenotype of Kindler syndrome associated with late diagnosis and skin cancer.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Basement Membrane; Blister; Carcinoma, Basal Cell; Cryosurgery; Delayed Diagnosis; Epidermolysis Bullosa; Female; Fluorouracil; Homozygote; Humans; Imiquimod; Male; Membrane Proteins; Middle Aged; Mutation; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Periodontal Diseases; Photosensitivity Disorders; Skin Neoplasms | 2010 |
[Surgical vs nonsurgical treatment of basal cell carcinoma].
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryosurgery; Fluorouracil; Follow-Up Studies; Hedgehog Proteins; Humans; Imiquimod; Interferons; Laser Therapy; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Phytotherapy; Plant Preparations; Risk Factors; Semecarpus; Skin Neoplasms; Treatment Outcome | 2010 |
Re-inventing intratumoral immunotherapy for melanoma.
Topics: Aminoquinolines; Antineoplastic Agents; BCG Vaccine; Cytokines; Humans; Imiquimod; Immunotherapy; Injections, Intralesional; Melanoma; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome | 2011 |
Successful treatment of recurrent extramammary Paget's disease of the penis and scrotum with imiquimod 5% cream.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Gels; Humans; Imiquimod; Male; Neoplasm Recurrence, Local; Osmolar Concentration; Paget Disease, Extramammary; Penile Neoplasms; Scrotum; Treatment Outcome | 2011 |
[Descriptive analysis of cutaneous recurrence patterns in patients with melanoma].
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Female; Humans; Imiquimod; Kaplan-Meier Estimate; Lymph Node Excision; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prognosis; Skin Neoplasms; Skin Ulcer | 2011 |
Conservative management of extramammary paget disease with imiquimod.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Skin Neoplasms; Treatment Outcome; Vulva; Vulvar Neoplasms | 2012 |
Treatment of locally recurrent mucosal melanoma with topical imiquimod.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Male; Melanoma; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Vaginal Neoplasms; Vulvar Neoplasms | 2011 |
Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream.
Topics: Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2012 |
Vulvar intraepithelial neoplasia: evaluation of treatment modalities.
Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Biopsy, Needle; Carcinoma in Situ; Cohort Studies; Female; Follow-Up Studies; Gynecologic Surgical Procedures; Humans; Imiquimod; Immunohistochemistry; Laser Therapy; Lasers, Gas; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Portugal; Retrospective Studies; Risk Assessment; Treatment Outcome; Vulvar Neoplasms; Young Adult | 2012 |
Conventional surgery compared with slow Mohs micrographic surgery in the treatment of lentigo maligna: a retrospective study of 62 cases.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm, Residual; Paraffin Embedding; Reoperation; Retrospective Studies; Skin Neoplasms; Skin Pigmentation; Treatment Outcome | 2012 |
Vulvar intraepithelial neoplasia (VIN 2/3): comparing clinical outcomes and evaluating risk factors for recurrence.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Combined Modality Therapy; Female; Humans; Imiquimod; Laser Therapy; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Proportional Hazards Models; Retrospective Studies; Risk Factors; Treatment Outcome; Vulva; Vulvar Neoplasms; Young Adult | 2012 |
Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer.
Topics: Administration, Topical; Aminoquinolines; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chemoradiotherapy; Cyclophosphamide; Cytokines; Dose Fractionation, Radiation; Drug Synergism; Histocompatibility Antigens Class I; Humans; Imiquimod; Immunologic Memory; Injections, Intraperitoneal; Intercellular Adhesion Molecule-1; Lymph Nodes; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Neoplasm Recurrence, Local; Neoplasm Transplantation; Skin Neoplasms; T-Lymphocytes; Toll-Like Receptor 7; Tumor Burden | 2012 |
Treatment of vulvar intraepithelial neoplasia with topical 5% imiquimod cream.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Female; Follow-Up Studies; Human papillomavirus 16; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Papillomavirus Infections; Remission Induction; Retrospective Studies; Treatment Outcome; Vaginal Creams, Foams, and Jellies; Vulvar Neoplasms | 2013 |
Topical imiquimod in the treatment of metastatic melanoma to skin.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dacarbazine; Female; Humans; Imiquimod; Interferon alpha-2; Interferon-alpha; Knee; Leg; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Scalp; Skin Neoplasms; Treatment Outcome | 2003 |
Management of cutaneous locoregional recurrences of melanoma: a new therapeutic perspective with imiquimod.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Melanoma; Neoplasm Recurrence, Local; Skin Neoplasms | 2003 |
Extensive lentigo maligna clearing with topical imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms | 2003 |
Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanoma; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Skin Neoplasms | 2003 |
Successful treatment of recurrent extramammary Paget's disease of the vulva with topical imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Vulvar Neoplasms | 2003 |
Medical treatment of nasal squamous papilloma with imiquimod cream.
Topics: Aminoquinolines; Humans; Imiquimod; Immunity, Cellular; Immunocompromised Host; Interferon Inducers; Male; Middle Aged; Neoplasm Recurrence, Local; Nose Neoplasms; Ointments; Papilloma; Treatment Outcome | 2003 |
Locoregional cutaneous metastases of malignant melanoma and their management.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Lymphatic Metastasis; Male; Melanoma; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Skin Neoplasms; Treatment Outcome | 2004 |
Imiquimod in the treatment of extensive recurrent lentigo maligna.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Recurrence, Local; Skin Neoplasms | 2005 |
To the editor: incompletely excised basal cell carcinoma treated with 5% imiquimod cream.
Topics: Adjuvants, Immunologic; Aminoquinolines; Carcinoma, Basal Cell; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms | 2005 |
Recurrent invasive basal cell carcinoma after radiation and imiquimod: a case report.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Nasal Cavity; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Nose Neoplasms; Skin Neoplasms | 2007 |
Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Diagnosis, Differential; Forehead; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms | 2007 |
Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Curettage; Female; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Treatment Outcome | 2007 |
Treatment of locally metastatic melanoma: a novel approach.
Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Imiquimod; Melanoma; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nicotinic Acids; Skin Neoplasms; Treatment Outcome | 2007 |
Self-administered topical imiquimod treatment of vulvar intraepithelial neoplasia. A report of four cases.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adult; Aminoquinolines; Carcinoma in Situ; Condylomata Acuminata; Drug Administration Schedule; Female; Humans; Imiquimod; Middle Aged; Neoplasm Recurrence, Local; Ointments; Papillomaviridae; Self Administration; Tumor Virus Infections; Vulvar Neoplasms | 2000 |
Treatment of vulvar intraepithelial neoplasia 2/3 with imiquimod.
Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Disease-Free Survival; Female; Humans; Imiquimod; Medical Records; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Texas; Treatment Outcome; Vulvar Neoplasms | 2002 |